EDMONTON, AB - Aurora Cannabis Inc (TSX:ACB). (NASDAQ: NASDAQ:ACB) (TSX: ACB), a Canadian-based global leader in medical cannabis, has been awarded Good Manufacturing Practice (GMP) certification by Australia's Therapeutic Goods Administration (TGA) for its production facilities, River and Ridge, located in Canada.
This certification, effective as of March 15, 2024, allows Aurora to export a broader range of cannabis products to the Australian market, including dried flower, resin cartridges, pastilles, and oils, in compliance with TGA regulations and TGO 93 standards.
The company's Vice President of Quality, Gorana Lakic, expressed pride in the achievement, emphasizing Aurora's commitment to quality and compliance. The certification is seen as a reinforcement of Aurora's dedication to the Australian medical cannabis market, which is currently estimated to be worth $400 million AUD and is the largest such market outside of North America.
Aurora, which is also the parent company of MedReleaf Australia, plans to continue introducing innovative products to the Australian market. Both Aurora and MedReleaf Australia are committed to providing Australian patients with reliable access to high-quality medical cannabis products and offering doctors a wider range of patient care options.
The company, known for its extensive portfolio of medical and recreational cannabis brands, operates in Canada, Europe, Australia, and South America. It is recognized for its science-driven approach and high-quality product offerings in the medical, wellness, and adult recreational markets.
This news release contains forward-looking statements regarding the company's intentions to grow and develop the Australian medical cannabis market further and to comply with regulatory standards. These statements are based on assumptions that management considers reasonable and are subject to risks and uncertainties that could cause actual results to differ materially.
The information in this article is based on a press release statement from Aurora Cannabis Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.